Mersana Therapeutics
Price & Volume
Stats
See more52W Range | $5.21-$30.39 |
Market Cap | $145.3M |
Shares Short | 54,446 |
Financials
See moreRevenue (12 Mos) | $33.1M |
Revenue Growth (YoY) | -12.6% |
Gross Profit (12 Mos) | -$35.8M |
Diluted EPS | -$13.95 |
News
See moreYahoo Finance • 30 days ago
Halper Sadeh LLC Encourages FFWM, MRSN, FSUN Shareholders to Contact the Firm to Discuss Their Rights
Yahoo Finance • last month
Halper Sadeh LLC Encourages CADE, MRSN, CDTX Shareholders to Contact the Firm to Discuss Their Rights
Yahoo Finance • last month
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana Therapeutics, Inc. (Nasdaq - MRSN), Cidara Therapeutics, Inc. (Nasdaq - CDTX), Cadence Bank (NYSE – CADE)
Yahoo Finance • last month
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
About
CEO | Dr. Martin H. Huber M.D. |
CFO | Mr. Brian C. DeSchuytner |
Address | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 102 |
